We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
James Yao MD

James C. Yao MD

Associate Professor, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Dr. James Yao is the Deputy Chairman in the Department of Gastrointestinal Medical Oncology at the University of Texas M.D. Anderson Cancer Center in Houston, Texas. His research focuses on the treatment of neuroendocrine tumors. Currently, he is the Vice Chair of North American Neuroendocrine Tumor Society (NANETS). He is also on the Neuroendocrine Task Force of GI Steering Committee for the National Cancer Institute (NCI). Dr. Yao is the PI on numerous clinical trials and has chaired three Phase III studies. Important publications that Dr. Yao has authored include:

  • Everolimus for Advanced Pancreatic Neuroendocrine Tumors. New England Journal of Medicine, February 2011.
  • One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States. Journal of Clinical Oncology, June 2008